Publications

2018

Sailer V, Schiffman MH, Kossai M, Cyrta J, Beg S, Sullivan B, et al. Bone biopsy protocol for advanced prostate cancer in the era of precision medicine. Cancer. 2018;124(5):1008-1015.
Nowinski S, Santaolalla A, O'Leary B, Loda M, Mirchandani A, Emberton M, et al. Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer. Oncotarget. 2018;9(16):12812-12824.
Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitiño MC, Kladney RD, et al. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene. 2018;37(32):4428-4442.
Larimer BM, Dubois F, Bloch E, Nesti S, Placzek M, Zadra G, et al. Specific F-FDHT Accumulation in Human Prostate Cancer Xenograft Murine Models Is Facilitated by Prebinding to Sex Hormone-Binding Globulin. J Nucl Med. 2018;59(10):1538-1543.
Wellberg EA, Kabos P, Gillen AE, Jacobsen BM, Brechbuhl HM, Johnson SJ, et al. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. JCI Insight. 2018;3(14).
Alexander J, Kendall J, McIndoo J, Rodgers L, Aboukhalil R, Levy D, et al. Utility of Single-Cell Genomics in Diagnostic Evaluation of Prostate Cancer. Cancer Res. 2018;78(2):348-358.
van der Touw W, Kang K, Luan Y, Ma G, Mai S, Qin L, et al. Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B. J Immunol. 2018;201(6):1727-1734.
Trindade AJ, Fan C, Bienstock B. Endoscopic resection of a rare subepithelial esophageal hamartoma. Dig Liver Dis. 2018;50(6):617.
Xu R, Yallowitz A, Qin A, Wu Z, Shin DY, Kim J-, et al. Targeting skeletal endothelium to ameliorate bone loss. Nat Med. 2018;24(6):823-833.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700